Atlas Trials

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Clinical trial NCT06122610 · COMPLETED

Trial details

NCT number
NCT06122610
Sponsor
University of Wisconsin, Madison
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroendocrine TumorsSomatostatin Receptor-positive Neuroendocrine Tumor
Start date
2025-03-07
Primary completion
2026-05-31
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.